Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study
- PMID: 30352005
- PMCID: PMC6746509
- DOI: 10.1080/21645515.2018.1539604
Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study
Abstract
Human papillomavirus is among the most common sexually transmitted infections in the world. Newcomers, defined in Canada as foreign-born individuals who are either immigrants or refugees, but may also include students and undocumented migrants, face numerous barriers to HPV vaccination. This study sought to understand, from the perspective of healthcare providers, barriers and facilitators to HPV vaccination, and recommendations to improve HPV vaccine uptake among newcomers. Semi-structured interviews were conducted with 10 healthcare providers between March and April 2018. Data were analyzed at the manifest level using a Qualitative Content Analysis approach. Categories of barriers to vaccination included: access, communication, knowledge, culture, and provider-related factors. Facilitators included targeted health promotion; understanding the relevance of HPV vaccination; trusting the healthcare system; and cultural sensitivity. Two overarching recommendations were to publicly fund the HPV vaccine, and enhance language- and culturally-appropriate health promotion activities. Further research should explore informational desires and needs from the perspective of newcomers to inform strategies to promote equitable HPV vaccine coverage.
Keywords: HPV; Human papillomavirus; healthcare providers; immunization; newcomers; qualitative methods; vaccination.
Figures
Similar articles
-
Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination.BMC Fam Pract. 2021 Jan 9;22(1):17. doi: 10.1186/s12875-020-01360-1. BMC Fam Pract. 2021. PMID: 33421999 Free PMC article.
-
Implementation of a Postpartum HPV Vaccination Program in a Southeast Texas Hospital: A Qualitative Study Evaluating Health Care Provider Acceptance.Matern Child Health J. 2016 Nov;20(Suppl 1):154-163. doi: 10.1007/s10995-016-2030-0. Matern Child Health J. 2016. PMID: 27316631 Free PMC article.
-
Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.Vaccine. 2012 Jun 22;30(30):4511-6. doi: 10.1016/j.vaccine.2012.04.062. Epub 2012 May 3. Vaccine. 2012. PMID: 22561142
-
Human Papillomavirus Infection and Vaccination.J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. J Pediatr Nurs. 2016. PMID: 26586310 Review.
-
USA dental health providers' role in HPV vaccine communication and HPV-OPC protection: a systematic review.Hum Vaccin Immunother. 2019;15(7-8):1863-1869. doi: 10.1080/21645515.2018.1558690. Epub 2019 Jan 30. Hum Vaccin Immunother. 2019. PMID: 30620632 Free PMC article.
Cited by
-
Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review.Hum Vaccin Immunother. 2023 Dec 31;19(1):2176640. doi: 10.1080/21645515.2023.2176640. Epub 2023 Feb 20. Hum Vaccin Immunother. 2023. PMID: 36803510 Free PMC article. Review.
-
Access to Vaccination for Newly Arrived Migrants: Developing a General Conceptual Framework for Understanding How to Improve Vaccination Coverage in European Countries.Int J Public Health. 2023 Aug 7;68:1605580. doi: 10.3389/ijph.2023.1605580. eCollection 2023. Int J Public Health. 2023. PMID: 37609078 Free PMC article.
-
"She vaccinated my baby and that's all…" Immunisation decision-making and experiences among refugee mothers resettled in Aotearoa New Zealand.BMC Public Health. 2023 Jul 13;23(1):1349. doi: 10.1186/s12889-023-16266-7. BMC Public Health. 2023. PMID: 37442991 Free PMC article.
-
Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand.Hum Vaccin Immunother. 2022 Nov 30;18(6):2131336. doi: 10.1080/21645515.2022.2131336. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315907 Free PMC article.
-
Understanding the health system barriers and enablers to childhood MMR and HPV vaccination among disadvantaged, minority or underserved populations in middle- and high-income countries: a systematic review.Eur J Public Health. 2024 Apr 3;34(2):368-374. doi: 10.1093/eurpub/ckad232. Eur J Public Health. 2024. PMID: 38183166 Free PMC article.
References
-
- World Health Organization Human papillomavirus (HPV) and cervical cancer [Internet]. 2018. [accessed 2018 April 10].http://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-...
-
- Public Health Agency of Canada Human Papillomavirus (HPV) [Internet]. 2017; 2018 https://www.canada.ca/en/public-health/services/infectious-diseases/sexu...
-
- Canadian Cancer Society’s Advisory Committee on Cancer Statistics Canadian cancer statistics special topic: HPV-associated cancers. Toronto (Canada): Canadian Cancer Society; 2016.
-
- Hillman RJ, Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Vardas E, Aranda C, Jessen H, Ferris DG, Coutlee F, et al. Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old. Clin Vaccine Immunol. 2012;19:261–267. doi:10.1128/CVI.05208-11. - DOI - PMC - PubMed
-
- Public Health Agency of Canada Canada’s Provincial and territorial routine (and catch-up) Vaccination routine schedule programs for infants and children - Canada.ca [Internet]. 2018. [accessed 2018 September 18]; https://www.canada.ca/en/public-health/services/provincial-territorial-i...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous